Study of Ayurveda formulaton in treatment of Polycystic Ovarian Syndrome (PCOS)

Evaluation of Rodhradi Gana Kashaya Ghana vati in Polycystic Ovarian Syndrome (PCOS)-An open clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/030995

Enrollment

Registered

2021-02-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E678- Other specified hyperalimentation Health Condition 2: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Rodhradi Gana Kashaya Vati: Dose - 500 mg After Food Frequency - Twice daily for 60 days Route of Administration - Oral Follow up - After 30 days Control Intervention1: Not Applicable:

Eligibility

Inclusion criteria

Inclusion criteria: 1) Both married and unmarried female patients of age group 16-40 years. 2) Patients with clinical features of PCOS like: Menstrual disorders-amenorrhoea, oligomenorrhoea, menorrhagia. 3) Hyperandrogenism- mild acne, increased terminal hair growth on face, neck, abdomen. 4) Acanthosis nigricans 5) Obesity-BMI >27(normal-18.5-24.5 )

Exclusion criteria

Exclusion criteria: 1. Patients suffering from acute and chronic medical and systemic diseases like hypertention, T.B, heart disease. 2. Severe anaemia (Hb 3. Hyperprolactenemia 3. Any organic lesions of reproductive tract like tuberculosis, carcinoma, congenital deformities or any pelvic pathology. 4. Thyroid dysfunction.

Design outcomes

Primary

Measure	Time frame
By this study we will be able understand the concept of PCOS in relation to Artavakshaya and provide evidence for indication of rodrahi gana in aratavavaha srotasTimepoint: 60 DAYS	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Prasanna V Savanur

KAHERs Shri BMK Ayurveda Mahavidyalaya

girijams.kaher@kleayurworld.edu.in9844362838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026